The effect of Fe2O3 and ZnO nanoparticles on cytotoxicity and glucose metabolism in lung epithelial cells

Journal of Applied Toxicology

Volumn 35, Issue 6, 2015, Pages 651-664

  Lai, Xiaofeng ^a   Wei, Yifang ^a   Zhao, Hu ^a   Chen, Suning ^b   Bu, Xin ^a   Lu, Fan ^a   Qu, Dingding ^a   Yao, Libo ^a   Zheng, Jianyong ^b   Zhang, Jian ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle arrest; Cytotoxicity; Glucose metabolism; Mitochondrial dysfunction; Nanoparticles; ROS

Indexed keywords

GLUCOSE; IRON OXIDE NANOPARTICLE; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; ZINC OXIDE NANOPARTICLE; FERRIC ION; FERRIC OXIDE; METAL NANOPARTICLE; ZINC OXIDE;

APOPTOSIS; ARTICLE; BIOENERGY; CHRONIC LUNG DISEASE; CONTROLLED STUDY; CYTOTOXICITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; G2 PHASE CELL CYCLE CHECKPOINT; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; M PHASE CELL CYCLE CHECKPOINT; PRIORITY JOURNAL; CELL CYCLE; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; LUNG; METABOLISM; MITOCHONDRION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT MUCOSA; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE; FERRIC COMPOUNDS; GLUCOSE; HUMANS; LUNG; METAL NANOPARTICLES; MITOCHONDRIA; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY MUCOSA; ZINC OXIDE;

EID: 84928207836     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.3128     Document Type: Article

References (69)

1. Akbarzadeh A, Samiei M, Davaran S. 2012. Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine. Nanoscale Res. Lett. 7: 144.
2. Alexis F, Pridgen EM, Langer R, Farokhzad OC. 2010. Nanoparticle technologies for cancer therapy. Handb. Exp. Pharmacol. 55-86. DOI: 10.1007/978-3-642-00477-3_2.
3. Aljarrah K, Mhaidat NM, Al-Akhras MA, Aldaher AN, Albiss B, Aledealat K, Alsheyab FM. 2012. Magnetic nanoparticles sensitize MCF-7 breast cancer cells to doxorubicin-induced apoptosis. World J. Surg. Oncol. 10: 62.
4. An JJ, Shi KJ, Wei W, Hua FY, Ci YL, Jiang Q, Li F, Wu P, Hui KY, Yang Y, Xu CM. 2013. The ROS/JNK/ATF2 pathway mediates selenite-induced leukemia NB4 cell cycle arrest and apoptosis in vitro and in vivo. Cell Death Dis. 4: e973.
5. Annibaldi A, Widmann C. 2010. Glucose metabolism in cancer cells. Curr. Opin. Clin. Nutr. Metab. Care 13: 466-470.
6. Bacchetta R, Moschini E, Santo N, Fascio U, Del Giacco L, Freddi S, Camatini M, Mantecca P. 2014. Evidence and uptake routes for Zinc oxide nanoparticles through the gastrointestinal barrier in Xenopus laevis. Nanotoxicology 8: 728-744.
7. Barroso G, Taylor S, Morshedi M, Manzur F, Gavino F, Oehninger S. 2006. Mitochondrial membrane potential integrity and plasma membrane translocation of phosphatidylserine as early apoptotic markers: a comparison of two different sperm subpopulations. Fertil. Steril. 85: 149-154.
8. Bava A, Gornati R, Cappellini F, Caldinelli L, Pollegioni L, Bernardini G. 2013. D-amino acid oxidase-nanoparticle system: a potential novel approach for cancer enzymatic therapy. Nanomed. Nanotechnol. Biol. Med. 8: 1797-1806.
9. Bruchez M Jr, Moronne M, Gin P, Weiss S, Alivisatos AP. 1998. Semiconductor nanocrystals as fluorescent biological labels. Science 281: 2013-2016.
10. Brunner TJ, Wick P, Manser P, Spohn P, Grass RN, Limbach LK, Bruinink A, Stark WJ. 2006. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ. Sci. Technol. 40: 4374-4381.
11. Buerki-Thurnherr T, Xiao L, Diener L, Arslan O, Hirsch C, Maeder-Althaus X, Grieder K, Wampfler B, Mathur S, Wick P, Krug HF. 2013. In vitro mechanistic study towards a better understanding of ZnO nanoparticle toxicity. Nanotoxicology 7: 402-416.
12. Bystrom LM, Guzman ML, Rivella S. 2014. Iron and reactive oxygen species: friends or foes of cancer cells? Antioxid. Redox Signal. 20: 1917-1924.
13. Campello S, Strappazzon F, Cecconi F. 2014. Mitochondrial dismissal in mammals, from protein degradation to mitophagy. Biochim. Biophys. Acta 1837: 451-460.
14. Chatterjee DK, Diagaradjane P, Krishnan S. 2011. Nanoparticle-mediated hyperthermia in cancer therapy. Ther. Deliv. 2: 1001-1014.
15. Cho WS, Duffin R, Howie SE, Scotton CJ, Wallace WA, Macnee W, Bradley M, Megson IL, Donaldson K. 2011. Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes. Part. Fibre Toxicol. 8: 27.
16. Conklin KA. 2004. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr. Cancer Ther. 3: 294-300.
17. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B, Kaplan MJ, Wapnir I, Dirbas FM, Somlo G, Garberoglio C, Paz B, Shen J, Lau SK, Quake SR, Brown JM, Weissman IL, Clarke MF. 2009. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458: 780-783.
18. Dong C, Yuan T, Wu Y, Wang Y, Fan TW, Miriyala S, Lin Y, Yao J, Shi J, Kang T, Lorkiewicz P, St Clair D, Hung MC, Evers BM, Zhou BP. 2013. Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer Cell 23: 316-331.
19. Downs I, Liu J, Aw TY, Adegboyega PA, Ajuebor MN. 2012. The ROS scavenger, NAC, regulates hepatic Valpha14iNKT cells signaling during Fas mAb-dependent fulminant liver failure. PLoS One 7: e38051.
20. Edelstein RL, Tamanaha CR, Sheehan PE, Miller MM, Baselt DR, Whitman LJ, Colton RJ. 2000. The BARC biosensor applied to the detection of biological warfare agents. Biosens. Bioelectron. 14: 805-813.
21. Filippi C, Pryde A, Cowan P, Lee T, Hayes P, Donaldson K, Plevris J, Stone V. 2014. Toxicology of ZnO and TiO nanoparticles on hepatocytes: Impact on metabolism and bioenergetics. Nanotoxicology. DOI: 10.3109/17435390.2014.895437.
22. Finkel T 2012. Signal transduction by mitochondrial oxidants. J. Biol. Chem. 287: 4434-4440.
23. Gelperina S, Kisich K, Iseman MD, Heifets L. 2005. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am. J. Respir. Crit. Care Med. 172: 1487-1490.
24. George S, Pokhrel S, Xia T, Gilbert B, Ji Z, Schowalter M, Rosenauer A, Damoiseaux R, Bradley KA, Madler L, Nel AE. 2010. Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron doping. ACS Nano 4: 15-29.
25. Gilbert B, Ono RK, Ching KA, Kim CS. 2009. The effects of nanoparticle aggregation processes on aggregate structure and metal uptake. J. Colloid Interface Sci. 339: 285-295.
26. Govender R, Phulukdaree A, Gengan RM, Anand K, Chuturgoon AA. 2013. Silver nanoparticles of Albizia adianthifolia: the induction of apoptosis in human lung carcinoma cell line. J. Nanobiotechnol. 11: 5.
27. Hallaj-Nezhadi S, Lotfipour F, Dass C. 2010. Nanoparticle-mediated interleukin-12 cancer gene therapy. J. Pharm. Pharm. Sci. 13: 472-485.
28. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell 144: 646-674.
29. Handy DE, Loscalzo J. 2012. Redox regulation of mitochondrial function. Antioxid. Redox Signal. 16: 1323-1367.
30. Hemnani T, Parihar MS. 1998. Reactive oxygen species and oxidative DNA damage. Indian J. Physiol. Pharmacol. 42: 440-452.
31. Issa B, Obaidat IM, Albiss BA, Haik Y. 2013. Magnetic nanoparticles: surface effects and properties related to biomedicine applications. Int. J. Mol. Sci. 14: 21266-21305.
32. Jiang D, Sullivan PG, Sensi SL, Steward O, Weiss JH. 2001. Zn(2+) induces permeability transition pore opening and release of pro-apoptotic peptides from neuronal mitochondria. J. Biol. Chem. 276: 47524-47529.
33. Jin Y, Lu Z, Ding K, Li J, Du X, Chen C, Sun X, Wu Y, Zhou J, Pan J. 2010. Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species. Cancer Res. 70: 2516-2527.
34. Kao YY, Chen YC, Cheng TJ, Chiung YM, Liu PS. 2012. Zinc oxide nanoparticles interfere with zinc ion homeostasis to cause cytotoxicity. Toxicol. Sci. 125: 462-472.
35. Kocbek P, Teskac K, Kreft ME, Kristl J. 2010. Toxicological aspects of long-term treatment of keratinocytes with ZnO and TiO2 nanoparticles. Small 6: 1908-1917.
36. Kroemer G, Galluzzi L, Brenner C. 2007. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 87: 99-163.
37. Lo YL, Wang W. 2013. Formononetin potentiates epirubicin-induced apoptosis via ROS production in HeLa cells in vitro. Chem. Biol. Interact. 205: 188-197.
38. Men K, Duan X, Wei XW, Gou ML, Huang MJ, Chen LJ, Qian ZY, Wei YQ. 2014. Nanoparticle-delivered quercetin for cancer therapy. Anticancer Agents Med Chem. 14: 826-832.
39. Miele E, Spinelli GP, Miele E, Di Fabrizio E, Ferretti E, Tomao S, Gulino A. 2012. Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy. Int. J. Nanomedicine 7: 3637-3657.
40. Molday RS, MacKenzie D. 1982. Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. J. Immunol. Methods 52: 353-367.
41. Nations S, Wages M, Canas JE, Maul J, Theodorakis C, Cobb GP. 2011. Acute effects of Fe(2)O(3), TiO(2), ZnO and CuO nanomaterials on Xenopus laevis. Chemosphere 83: 1053-1061.
42. Nikodemowicz M 2008. The environment and human respiratory system. Przegl. Lek. 65(Suppl 2): 12-17.
43. Perry SW, Norman JP, Barbieri J, Brown EB, Gelbard HA. 2011. Mitochondrial membrane potential probes and the proton gradient: a practical usage guide. Biotechniques 50: 98-115.
44. Pujalte I, Passagne I, Brouillaud B, Treguer M, Durand E, Ohayon-Courtes C, L'Azou B. 2011. Cytotoxicity and oxidative stress induced by different metallic nanoparticles on human kidney cells. Part. Fibre Toxicol. 8: 10.
45. Qian Y, Wang X, Liu Y, Li Y, Colvin RA, Tong L, Wu S, Chen X. 2014. Extracellular ATP is internalized by macropinocytosis and induces intracellular ATP increase and drug resistance in cancer cells. Cancer Lett. 351: 242-251.
46. Quast SA, Berger A, Eberle J. 2013. ROS-dependent phosphorylation of Bax by wortmannin sensitizes melanoma cells for TRAIL-induced apoptosis. Cell Death Dis. 4: e839.
47. Sayes CM, Wahi R, Kurian PA, Liu Y, West JL, Ausman KD, Warheit DB, Colvin VL. 2006. Correlating nanoscale titania structure with toxicity: a cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cells. Toxicol. Sci. 92: 174-185.
48. Sharma V, Shukla RK, Saxena N, Parmar D, Das M, Dhawan A. 2009. DNA damaging potential of zinc oxide nanoparticles in human epidermal cells. Toxicol. Lett. 185: 211-218.
49. Sharma V, Anderson D, Dhawan A. 2011. Zinc oxide nanoparticles induce oxidative stress and genotoxicity in human liver cells (HepG2). J. Biomed. Nanotechnol. 7: 98-99.
50. Shen B, He PJ, Shao CL. 2013. Norcantharidin induced DU145 cell apoptosis through ROS-mediated mitochondrial dysfunction and energy depletion. PLoS One 8: e84610.
51. Siddiqui MA, Alhadlaq HA, Ahmad J, Al-Khedhairy AA, Musarrat J, Ahamed M. 2013. Copper oxide nanoparticles induced mitochondria mediated apoptosis in human hepatocarcinoma cells. PLoS One 8: e69534.
52. Simonnet H, Alazard N, Pfeiffer K, Gallou C, Beroud C, Demont J, Bouvier R, Schagger H, Godinot C. 2002. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. Carcinogenesis 23: 759-768.
53. Sun J, Wang S, Zhao D, Hun FH, Weng L, Liu H. 2011. Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells: cytotoxicity, permeability, and inflammation of metal oxide nanoparticles. Cell Biol. Toxicol. 27: 333-342.
54. Syama S, Sreekanth PJ, Varma HK, Mohanan PV. 2014. Zinc oxide nanoparticles induced oxidative stress in mouse bone marrow mesenchymal stem cells. Toxicol. Mech. Methods 1-10. DOI: 10.3109/15376516.2014.956914.
55. Taylor WR, Stark GR. 2001. Regulation of the G2/M transition by p53. Oncogene 20: 1803-1815.
56. Tucci P, Porta G, Agostini M, Dinsdale D, Iavicoli I, Cain K, Finazzi-Agro A, Melino G, Willis A. 2013. Metabolic effects of TiO2 nanoparticles, a common component of sunscreens and cosmetics, on human keratinocytes. Cell Death Dis. 4: e549.
57. Wahab R, Siddiqui MA, Saquib Q, Dwivedi S, Ahmad J, Musarrat J, Al-Khedhairy AA, Shin HS. 2014. ZnO nanoparticles induced oxidative stress and apoptosis in HepG2 and MCF-7 cancer cells and their antibacterial activity. Colloids Surf. B Biointerfaces 117: 267-276.
58. Wan R, Mo Y, Feng L, Chien S, Tollerud DJ, Zhang Q. 2012. DNA damage caused by metal nanoparticles: involvement of oxidative stress and activation of ATM. Chem. Res. Toxicol. 25: 1402-1411.
59. Wang J, Yi J. 2008. Cancer cell killing via ROS: to increase or decrease, that is the question. Cancer Biol. Ther. 7: 1875-1884.
60. Wang J, Deng X, Zhang F, Chen D, Ding W. 2014. ZnO nanoparticle-induced oxidative stress triggers apoptosis by activating JNK signaling pathway in cultured primary astrocytes. Nanoscale Res. Lett. 9: 117.
61. Warburg O 1956. On the origin of cancer cells. Science 123: 309-314.
62. Wells MA, Abid A, Kennedy IM, Barakat AI. 2012. Serum proteins prevent aggregation of Fe2O3 and ZnO nanoparticles. Nanotoxicology 6: 837-846.
63. Xia T, Kovochich M, Liong M, Madler L, Gilbert B, Shi H, Yeh JI, Zink JI, Nel AE. 2008. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2: 2121-2134.
64. Xu M, Fujita D, Kajiwara S, Minowa T, Li X, Takemura T, Iwai H, Hanagata N. 2010. Contribution of physicochemical characteristics of nano-oxides to cytotoxicity. Biomaterials 31: 8022-8031.
65. Yang C, He X, Song L, Zhan X, Zhang Y, Dou J, Gu N. 2014. Gamma-Fe2O3 nanoparticles increase therapeutic efficacy of combination with paclitaxel and anti-ABCG2 monoclonal antibody on multiple myeloma cancer stem cells in mouse model. J. Biomed. Nanotechnol. 10: 336-344.
66. Zhang J, Li F, Liu X, Shen L, Liu J, Su J, Zhang W, Deng Y, Wang L, Liu N, Han W, Zhang J, Ji S, Yang A, Han H, Yao L. 2006. The repression of human differentiation-related gene NDRG2 expression by Myc via Miz-1-dependent interaction with the NDRG2 core promoter. J. Biol. Chem. 281: 39159-39168.
67. Zhang S, Gong M, Zhang D, Yang H, Gao F, Zou L. 2014. Thiol-PEG-carboxyl-stabilized Fe(2)O (3)/Au nanoparticles targeted to CD105: synthesis, characterization and application in MR imaging of tumor angiogenesis. Eur. J. Radiol. 83: 1190-1198.
68. Zhu MT, Wang Y, Feng WY, Wang B, Wang M, Ouyang H, Chai ZF. 2010. Oxidative stress and apoptosis induced by iron oxide nanoparticles in cultured human umbilical endothelial cells. J. Nanosci. Nanotechnol. 10: 8584-8590.
69. Zou C, Wang Y, Shen Z. 2005. 2-NBDG as a fluorescent indicator for direct glucose uptake measurement. J. Biochem. Biophys. Methods 64: 207-215.